{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T11:48:31Z","timestamp":1782215311093,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"7417","license":[{"start":{"date-parts":[[2012,9,9]],"date-time":"2012-09-09T00:00:00Z","timestamp":1347148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"},{"start":{"date-parts":[[2012,9,9]],"date-time":"2012-09-09T00:00:00Z","timestamp":1347148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2012,9,27]]},"DOI":"10.1038\/nature11404","type":"journal-article","created":{"date-parts":[[2012,9,7]],"date-time":"2012-09-07T12:08:45Z","timestamp":1347019725000},"page":"519-525","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3525,"title":["Comprehensive genomic characterization of squamous cell lung cancers"],"prefix":"10.1038","volume":"489","author":[{"name":"The Cancer Genome Atlas Research Network","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,9]]},"reference":[{"key":"BFnature11404_CR1","unstructured":"World Health Organization Cancer, fact sheet no. 297 \u3008\n                    http:\/\/www.who.int\/mediacentre\/factsheets\/fs297\/en\/\n                    \n                  \u3009 (accessed, February 2012)"},{"key":"BFnature11404_CR2","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nature05945","volume":"448","author":"M Soda","year":"2007","unstructured":"Soda, M. et al. Identification of the transforming EML4\u2013ALK fusion gene in non-small-cell lung cancer. Nature 448, 561\u2013566 (2007)","journal-title":"Nature"},{"key":"BFnature11404_CR3","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.1099314","volume":"304","author":"JG Paez","year":"2004","unstructured":"Paez, J. G. et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304, 1497\u20131500 (2004)","journal-title":"Science"},{"key":"BFnature11404_CR4","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1056\/NEJMoa040938","volume":"350","author":"TJ Lynch","year":"2004","unstructured":"Lynch, T. J. et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 350, 2129\u20132139 (2004)","journal-title":"N. Engl. J. Med."},{"key":"BFnature11404_CR5","doi-asserted-by":"publisher","first-page":"13306","DOI":"10.1073\/pnas.0405220101","volume":"101","author":"W Pao","year":"2004","unstructured":"Pao, W. et al. EGF receptor gene mutations are common in lung cancers from \u201cnever smokers\u201d and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc. Natl Acad. Sci. USA 101, 13306\u201313311 (2004)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature11404_CR6","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1093\/annonc\/mdr150","volume":"22","author":"E Felip","year":"2011","unstructured":"Felip, E., Gridelli, C., Baas, P., Rosell, R. & Stahel, R. Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy. Ann. Oncol. 22, 1507\u20131519 (2011)","journal-title":"Ann. Oncol."},{"key":"BFnature11404_CR7","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1101\/gr.133645.111","volume":"22","author":"YS Ju","year":"2012","unstructured":"Ju, Y. S. et al. A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing. Genome Res. 22, 436\u2013445 (2012)","journal-title":"Genome Res."},{"key":"BFnature11404_CR8","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1158\/1078-0432.CCR-11-2109","volume":"18","author":"N Rekhtman","year":"2012","unstructured":"Rekhtman, N. et al. Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR\/KRAS and presence of PIK3CA\/AKT1 mutations. Clin. Cancer. Res. 18, 1167\u20131176 (2012)","journal-title":"Clin. Cancer. Res."},{"key":"BFnature11404_CR9","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/ng.465","volume":"41","author":"AJ Bass","year":"2009","unstructured":"Bass, A. J. et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nature Genet. 41, 1238\u20131242 (2009)","journal-title":"Nature Genet."},{"key":"BFnature11404_CR10","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.4161\/cbt.8.21.9764","volume":"8","author":"AH Ramos","year":"2009","unstructured":"Ramos, A. H. et al. Amplification of chromosomal segment 4q12 in non-small cell lung cancer. Cancer Biol. Ther. 8, 2042\u20132050 (2009)","journal-title":"Cancer Biol. Ther."},{"key":"BFnature11404_CR11","doi-asserted-by":"publisher","first-page":"13568","DOI":"10.1073\/pnas.0806268105","volume":"105","author":"T Shibata","year":"2008","unstructured":"Shibata, T. et al. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc. Natl Acad. Sci. USA 105, 13568\u201313573 (2008)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature11404_CR12","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/nature09208","volume":"466","author":"Z Kan","year":"2010","unstructured":"Kan, Z. et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466, 869\u2013873 (2010)","journal-title":"Nature"},{"key":"BFnature11404_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1158\/2159-8274.CD-11-0005","volume":"1","author":"PS Hammerman","year":"2011","unstructured":"Hammerman, P. S., Sos, M. L., Ramos, A. & Xu, C. Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer. Cancer Discovery 1, 78 (2011)","journal-title":"Cancer Discovery"},{"key":"BFnature11404_CR14","doi-asserted-by":"publisher","first-page":"62ra93","DOI":"10.1126\/scitranslmed.3001451","volume":"2","author":"J Weiss","year":"2010","unstructured":"Weiss, J. et al. Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. Sci. Transl. Med. 2, 62ra93 (2010)","journal-title":"Sci. Transl. Med."},{"key":"BFnature11404_CR15","doi-asserted-by":"publisher","first-page":"e20351","DOI":"10.1371\/journal.pone.0020351","volume":"6","author":"A Dutt","year":"2011","unstructured":"Dutt, A. et al. Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer. PLoS One 6, e20351 (2011)","journal-title":"PLoS One"},{"key":"BFnature11404_CR16","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1136\/tc.2007.022582","volume":"17","author":"SA Kenfield","year":"2008","unstructured":"Kenfield, S. A., Wei, E. K., Stampfer, M. J., Rosner, B. A. & Colditz, G. A. Comparison of aspects of smoking among the four histological types of lung cancer. Tob. Control 17, 198\u2013204 (2008)","journal-title":"Tob. Control"},{"key":"BFnature11404_CR17","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609\u2013615 (2011)","DOI":"10.1038\/nature10166"},{"key":"BFnature11404_CR18","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061\u20131068 (2008)","DOI":"10.1038\/nature07385"},{"key":"BFnature11404_CR19","doi-asserted-by":"publisher","first-page":"9625","DOI":"10.1073\/pnas.0504126102","volume":"102","author":"G Tonon","year":"2005","unstructured":"Tonon, G. et al. High-resolution genomic profiles of human lung cancer. Proc. Natl Acad. Sci. USA 102, 9625\u20139630 (2005)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature11404_CR20","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nature08822","volume":"463","author":"R Beroukhim","year":"2010","unstructured":"Beroukhim, R. et al. The landscape of somatic copy-number alteration across human cancers. Nature 463, 899\u2013905 (2010)","journal-title":"Nature"},{"key":"BFnature11404_CR21","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011)","journal-title":"Genome Biol."},{"key":"BFnature11404_CR22","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1126\/science.1208130","volume":"333","author":"N Stransky","year":"2011","unstructured":"Stransky, N. et al. The mutational landscape of head and neck squamous cell carcinoma. Science 333, 1157\u20131160 (2011)","journal-title":"Science"},{"key":"BFnature11404_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nature09837","volume":"471","author":"MA Chapman","year":"2011","unstructured":"Chapman, M. A. et al. Initial genome sequencing and analysis of multiple myeloma. Nature 471, 467\u2013472 (2011)","journal-title":"Nature"},{"key":"BFnature11404_CR24","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1126\/science.1206923","volume":"333","author":"N Agrawal","year":"2011","unstructured":"Agrawal, N. et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1 . Science 333, 1154\u20131157 (2011)","journal-title":"Science"},{"key":"BFnature11404_CR25","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/ng.936","volume":"43","author":"AJ Bass","year":"2011","unstructured":"Bass, A. J. et al. Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion. Nature Genet. 43, 964\u2013968 (2011)","journal-title":"Nature Genet."},{"key":"BFnature11404_CR26","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature09744","volume":"470","author":"MF Berger","year":"2011","unstructured":"Berger, M. F. et al. The genomic complexity of primary human prostate cancer. Nature 470, 214\u2013220 (2011)","journal-title":"Nature"},{"key":"BFnature11404_CR27","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nature08645","volume":"462","author":"PJ Stephens","year":"2009","unstructured":"Stephens, P. J. et al. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 462, 1005\u20131010 (2009)","journal-title":"Nature"},{"key":"BFnature11404_CR28","doi-asserted-by":"publisher","first-page":"e420","DOI":"10.1371\/journal.pmed.0030420","volume":"3","author":"A Singh","year":"2006","unstructured":"Singh, A. et al. Dysfunctional KEAP1\u2013NRF2 interaction in non-small-cell lung cancer. PLoS Med. 3, e420 (2006)","journal-title":"PLoS Med."},{"key":"BFnature11404_CR29","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1089\/ars.2010.3219","volume":"13","author":"A Singh","year":"2010","unstructured":"Singh, A., Bodas, M., Wakabayashi, N., Bunz, F. & Biswal, S. Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance. Antioxid. Redox Signal. 13, 1627\u20131637 (2010)","journal-title":"Antioxid. Redox Signal."},{"key":"BFnature11404_CR30","doi-asserted-by":"publisher","first-page":"i237","DOI":"10.1093\/bioinformatics\/btq182","volume":"26","author":"CJ Vaske","year":"2010","unstructured":"Vaske, C. J. et al. Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics 26, i237\u2013i245 (2010)","journal-title":"Bioinformatics"},{"key":"BFnature11404_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/path.2789","volume":"223","author":"JC Aster","year":"2011","unstructured":"Aster, J. C., Blacklow, S. C. & Pear, W. S. Notch signalling in T-cell lymphoblastic leukaemia\/lymphoma and other haematological malignancies. J. Pathol. 223, 263\u2013274 (2011)","journal-title":"J. Pathol."},{"key":"BFnature11404_CR32","doi-asserted-by":"publisher","first-page":"17761","DOI":"10.1073\/pnas.1114669108","volume":"108","author":"NJ Wang","year":"2011","unstructured":"Wang, N. J. et al. Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc. Natl Acad. Sci. USA 108, 17761\u201317766 (2011)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature11404_CR33","doi-asserted-by":"publisher","first-page":"10680","DOI":"10.1158\/0008-5472.CAN-05-1404","volume":"65","author":"H Osada","year":"2005","unstructured":"Osada, H., Tatematsu, Y., Yatabe, Y., Horio, Y. & Takahashi, T. ASH1 gene is a specific therapeutic target for lung cancers with neuroendocrine features. Cancer Res. 65, 10680\u201310685 (2005)","journal-title":"Cancer Res."},{"key":"BFnature11404_CR34","doi-asserted-by":"publisher","first-page":"4864","DOI":"10.1158\/1078-0432.CCR-10-0199","volume":"16","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson, M. D. et al. Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types. Clin. Cancer Res. 16, 4864\u20134875 (2010)","journal-title":"Clin. Cancer Res."},{"key":"BFnature11404_CR35","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/modpathol.2011.173","volume":"25","author":"JA Bishop","year":"2011","unstructured":"Bishop, J. A. et al. p40 (\u0394Np63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. Mod. Pathol. 25, 405\u2013415 (2011)","journal-title":"Mod. Pathol."},{"key":"BFnature11404_CR36","first-page":"7113","volume":"63","author":"PP Massion","year":"2003","unstructured":"Massion, P. P. et al. Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res. 63, 7113\u20137121 (2003)","journal-title":"Cancer Res."},{"key":"BFnature11404_CR37","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1093\/bioinformatics\/btp543","volume":"25","author":"R Shen","year":"2009","unstructured":"Shen, R., Olshen, A. B. & Ladanyi, M. Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis. Bioinformatics 25, 2906\u20132912 (2009)","journal-title":"Bioinformatics"},{"key":"BFnature11404_CR38","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1586\/14737140.6.4.515","volume":"6","author":"H Wikman","year":"2006","unstructured":"Wikman, H. & Kettunen, E. Regulation of the G1\/S phase of the cell cycle and alterations in the RB pathway in human lung cancer. Expert Rev. Anticancer Ther. 6, 515\u2013530 (2006)","journal-title":"Expert Rev. Anticancer Ther."},{"key":"BFnature11404_CR39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/JTO.0b013e3182021f3e","volume":"6","author":"RK Kancha","year":"2011","unstructured":"Kancha, R. K., Peschel, C. & Duyster, J. The epidermal growth factor receptor-L861Q mutation increases kinase activity without leading to enhanced sensitivity toward epidermal growth factor receptor kinase inhibitors. J. Thorac. Oncol. 6, 387\u2013392 (2011)","journal-title":"J. Thorac. Oncol."},{"key":"BFnature11404_CR40","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1093\/nar\/gkr407","volume":"39","author":"B Reva","year":"2011","unstructured":"Reva, B., Antipin, Y. & Sander, C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res. 39, e118 (2011)","journal-title":"Nucleic Acids Res."},{"key":"BFnature11404_CR41","doi-asserted-by":"publisher","first-page":"S433","DOI":"10.1097\/JTO.0b013e3181fd6fe1","volume":"5","author":"R Govindan","year":"2010","unstructured":"Govindan, R. Summary of the proceedings from the 10th annual meeting of molecularly targeted therapy in non-small cell lung cancer. J. Thorac. Oncol. 5, S433 (2010)","journal-title":"J. Thorac. Oncol."},{"key":"BFnature11404_CR42","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature07423","volume":"455","author":"L Ding","year":"2008","unstructured":"Ding, L. et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455, 1069\u20131075 (2008)","journal-title":"Nature"},{"key":"BFnature11404_CR43","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1101\/gr.125567.111","volume":"22","author":"G Ciriello","year":"2012","unstructured":"Ciriello, G., Cerami, E., Sander, C. & Schultz, N. Mutual exclusivity analysis identifies oncogenic network modules. Genome Res. 22, 398\u2013406 (2012)","journal-title":"Genome Res."},{"key":"BFnature11404_CR44","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011)","journal-title":"Cell"},{"key":"BFnature11404_CR45","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1200\/JCO.2009.26.7609","volume":"28","author":"JR Brahmer","year":"2010","unstructured":"Brahmer, J. R. et al. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J. Clin. Oncol. 28, 3167\u20133175 (2010)","journal-title":"J. Clin. Oncol."},{"key":"BFnature11404_CR46","doi-asserted-by":"publisher","first-page":"7531","DOI":"10.1200\/jco.2010.28.15_suppl.7531","volume":"28","author":"TJ Lynch","year":"2010","unstructured":"Lynch, T. J. et al. Phase II trial of ipilimumab (IPI) and paclitaxel\/carboplatin (P\/C) in first-line stage IIIb\/IV non-small cell lung cancer (NSCLC). J. Clin. Oncol. 28, 7531 (2010)","journal-title":"J. Clin. Oncol."}],"updated-by":[{"DOI":"10.1038\/nature11666","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2012,11,7]],"date-time":"2012-11-07T00:00:00Z","timestamp":1352246400000}}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature11404.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature11404","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature11404.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:03:34Z","timestamp":1684418614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature11404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,9]]},"references-count":46,"journal-issue":{"issue":"7417","published-print":{"date-parts":[[2012,9,27]]}},"alternative-id":["BFnature11404"],"URL":"https:\/\/doi.org\/10.1038\/nature11404","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717960611.793463544","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,9]]},"assertion":[{"value":"9 March 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}